Avantor, Inc. (AVTR)
Healthcare
- Fundamental
- 3
- Sentiment
- 3
- Technical
- 4
Bullish breakout plan: buy stop 13.84 above the 2-session shelf; structural stop 13.10 under the Aug. 4 low cluster; targets 15.12 and 16.08; R/R 1.73.
Company overview
Avantor, Inc., headquartered in Radnor, Pennsylvania, is a global supplier of essential products and specialized services. It serves industries such as biopharmaceuticals, healthcare, and advanced technology with high-purity chemicals, laboratory supplies, and advanced equipment. The company also offers services like laboratory support and biopharmaceutical material development.
Fundamental
fairAvantor shows cash generation and liquidity, but faces revenue decline and margin pressure.
Score 3 (Mixed): Avantor remains cash-generative (FY2025 operating cash flow $624M vs. ~$129M capex) and liquid (10-Q 2026-06-30: $307M cash plus ~$1.38B unused revolver availability), but the core business has been shrinking and margins have eased (2021–2025 revenue CAGR ~-3%; adjusted EBITDA margin 16.3% in 2025 vs. 17.7% in 2024). The $785M goodwill impairment and resulting 2025 GAAP net loss underscore execution risk; valuation looks reasonable on EV/Sales (~1.9x) and free-cash-flow yield (~5.5%) but needs evidence of sustained stabilization for a higher score.
Sentiment
fairMedia tone improved post-earnings, but retail and catalyst activity remain minimal.
Near-term tone improved after Avantor’s Q2 2026 earnings release (2026-07-29, announced), but the next-30-trading-day forward catalyst calendar looks thin and baseline coverage still flags destocking/execution risk. No regulator-confirmed investigations surfaced (only plaintiff-law-firm solicitation noise) and Reddit engagement is negligible, keeping conviction mid.
Technical
goodAvantor maintains a bullish trend, requiring confirmation above recent highs for entry.
Trend remains bullish with price above SMA20/50/200 and EMA9/21, RSI14 at 68.05, MACD positive above signal, and ADX14 at 55.30. The setup loses a point because AVTR is still digesting its earnings-gap surge below WMA9 and the latest daily VWAP, with nearby overhead supply from 14.00 to 14.62, so confirmation is needed.
You’re looking at 2026-08-06 — about 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.